ACN vs CPHI · P/E 24, rev $17.60B vs rev $4.1M
Accenture plc (ACN) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the ACN and CPHI stock pages for the full models.
Not investment advice.